Secretion and assembly of calicivirus-like particles in high-cell-density yeast fermentations: strategies based on a recombinant non-specific BPTI-Kunitz-type protease inhibitor

[1]  J. Gatehouse,et al.  Optimising expression of the recombinant fusion protein biopesticide ω-hexatoxin-Hv1a/GNA in Pichia pastoris: sequence modifications and a simple method for the generation of multi-copy strains , 2014, Journal of Industrial Microbiology & Biotechnology.

[2]  Anton Glieder,et al.  New opportunities by synthetic biology for biopharmaceutical production in Pichia pastoris , 2013, Current opinion in biotechnology.

[3]  R. Menna-Barreto,et al.  Effects of a marine serine protease inhibitor on viability and morphology of Trypanosoma cruzi, the agent of Chagas disease. , 2013, Acta tropica.

[4]  V. Young,et al.  An Enhanced Heterologous Virus-Like Particle for Human Papillomavirus Type 16 Tumour Immunotherapy , 2013, PloS one.

[5]  Caroline F. B. Mourão,et al.  Protease Inhibitors from Marine Venomous Animals and Their Counterparts in Terrestrial Venomous Animals , 2013, Marine drugs.

[6]  Alison Nordon,et al.  Towards better understanding of an industrial cell factory: investigating the feasibility of real-time metabolic flux analysis in Pichia pastoris , 2013, Microbial Cell Factories.

[7]  F. Parra,et al.  Conformational and Thermal Stability Improvements for the Large-Scale Production of Yeast-Derived Rabbit Hemorrhagic Disease Virus-Like Particles as Multipurpose Vaccine , 2013, PloS one.

[8]  Susann Müller,et al.  From multi-omics to basic structures of biological systems. , 2013, Current opinion in biotechnology.

[9]  T. Pons,et al.  Structural insights into serine protease inhibition by a marine invertebrate BPTI Kunitz-type inhibitor. , 2012, Journal of structural biology.

[10]  T. Pons,et al.  Structure of the recombinant BPTI/Kunitz-type inhibitor rShPI-1A from the marine invertebrate Stichodactyla helianthus. , 2012, Acta crystallographica. Section F, Structural biology and crystallization communications.

[11]  E. Boido,et al.  Growth of non-Saccharomyces yeasts affects nutrient availability for Saccharomyces cerevisiae during wine fermentation. , 2012, International journal of food microbiology.

[12]  J. Bárcena,et al.  Virus-like particles: The new frontier of vaccines for animal viral infections , 2012, Veterinary Immunology and Immunopathology.

[13]  Gabriel Potvin,et al.  Bioprocess engineering aspects of heterologous protein production in Pichia pastoris: A review , 2012 .

[14]  V. Young,et al.  Virus-like particles and α-galactosylceramide form a self-adjuvanting composite particle that elicits anti-tumor responses. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[15]  B. Trus,et al.  Epitope Insertion at the N-Terminal Molecular Switch of the Rabbit Hemorrhagic Disease Virus T=3 Capsid Protein Leads to Larger T=4 Capsids , 2012, Journal of Virology.

[16]  J. Le Pendu,et al.  Rabbit haemorrhagic disease (RHD) and rabbit haemorrhagic disease virus (RHDV): a review , 2012, Veterinary Research.

[17]  J. Parkes,et al.  Rabbit haemorrhagic disease: advantages of cELISA in assessing immunity in wild rabbits (Oryctolagus cuniculus). , 2011, Veterinary microbiology.

[18]  A. Melcher,et al.  Enhancing the immunogenicity of tumour lysate-loaded dendritic cell vaccines by conjugation to virus-like particles , 2011, British Journal of Cancer.

[19]  R. García-Fernández,et al.  Recombinant expression of ShPI-1A, a non-specific BPTI-Kunitz-type inhibitor, and its protection effect on proteolytic degradation of recombinant human miniproinsulin expressed in Pichia pastoris. , 2011, FEMS yeast research.

[20]  L. Capucci,et al.  Single dose adenovirus vectored vaccine induces a potent and long-lasting immune response against rabbit hemorrhagic disease virus after parenteral or mucosal administration. , 2011, Veterinary immunology and immunopathology.

[21]  M. Arévalo-Villena,et al.  Co-inoculation of different Saccharomyces cerevisiae strains and influence on volatile composition of wines. , 2011, Food microbiology.

[22]  P. Alves,et al.  Large-scale production and purification of VLP-based vaccines , 2011, Journal of Invertebrate Pathology.

[23]  M. Peacey,et al.  Virus-like particles from rabbit hemorrhagic disease virus can induce an anti-tumor response. , 2008, Vaccine.

[24]  M. Peacey,et al.  Versatile RHDV virus‐like particles: Incorporation of antigens by genetic modification and chemical conjugation , 2007, Biotechnology and bioengineering.

[25]  J. Morgado-Díaz,et al.  Effects of serine protease inhibitors on viability and morphology of Leishmania (Leishmania) amazonensis promastigotes , 2007, Parasitology Research.

[26]  R. Lleonart,et al.  Molecular and antigenic characterization of rabbit hemorrhagic disease virus isolated in Cuba indicates a distinct antigenic subtype , 2007, Archives of Virology.

[27]  R. Lleonart,et al.  High-level expression and immunogenic properties of the recombinant rabbit hemorrhagic disease virus VP60 capsid protein obtained in Pichia pastoris. , 2005, Journal of biotechnology.

[28]  Jayanta Sinha,et al.  Causes of proteolytic degradation of secreted recombinant proteins produced in methylotrophic yeast Pichia pastoris: case study with recombinant ovine interferon-tau. , 2005, Biotechnology and bioengineering.

[29]  R. Glass,et al.  Inter- and Intragenus Structural Variations in Caliciviruses and Their Functional Implications , 2004, Journal of Virology.

[30]  R. Roca,et al.  The coat protein of Rabbit hemorrhagic disease virus contains a molecular switch at the N-terminal region facing the inner surface of the capsid. , 2004, Virology.

[31]  M. Alting-Mees,et al.  Optimal conditions for the expression of a single-chain antibody (scFv) gene in Pichia pastoris. , 2003, Protein expression and purification.

[32]  T. Hynes,et al.  Crystal structures of bovine chymotrypsin and trypsin complexed to the inhibitor domain of alzheimer's amyloid β‐protein precursor (APPI) and basic pancreatic trypsin inhibitor (BPTI): Engineering of inhibitors with altered specificities , 1997, Protein science : a publication of the Protein Society.

[33]  W. Antuch,et al.  Purification, characterization and immobilization of proteinase inhibitors from Stichodactyla helianthus. , 1996, Toxicon : official journal of the International Society on Toxinology.

[34]  E. Brocchi,et al.  Antigenicity of the rabbit hemorrhagic disease virus studied by its reactivity with monoclonal antibodies. , 1995, Virus research.

[35]  R. Tibshirani,et al.  An Introduction to the Bootstrap , 1995 .

[36]  F. Parra,et al.  The amino terminal sequence of VP60 from rabbit hemorrhagic disease virus supports its putative subgenomic origin. , 1993, Virus research.

[37]  K. Wüthrich,et al.  The NMR solution structure of a Kunitz-type proteinase inhibitor from the sea anemone Stichodactyla helianthus. , 1993, European journal of biochemistry.

[38]  V. Dijl.  Handbook of Proteolytic Enzymes, third edition , 2013 .

[39]  U. Mortensen,et al.  Carboxypeptidase C including Carboxypeptidase Y , 2013 .

[40]  Michael Sauer,et al.  Recombinant protein production in yeasts. , 2012, Methods in molecular biology.

[41]  C. Batt,et al.  Protein secretion in Pichia pastoris and advances in protein production , 2011, Applied Microbiology and Biotechnology.

[42]  P. Alfonso,et al.  Biochemical and structural characterization of RHDV capsid protein variants produced in Pichia pastoris: advantages for immunization strategies and vaccine implementation. , 2009, Antiviral research.

[43]  J. Cregg,et al.  Introduction to Pichia pastoris. , 1998, Methods in molecular biology.

[44]  Neil D. Rawlings,et al.  Handbook of proteolytic enzymes , 1998 .

[45]  L. Guarente,et al.  High-efficiency transformation of yeast by electroporation. , 1991, Methods in enzymology.